Go to Page # Page of 25
loading

Reaching Value Inflection Points in Neurodegenerative Diseases

 Bionure Farma
  25th-Jun-2019
Description: Bionure ambition is to propose new disease-modifier treatments able to slow down, stop or reverse the evolution into disability in patients suffering from neuronal damage.
Views: 1211
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: Bionure Farma
 ‐ More of their Presentations
SEMICONDUCTOR ANALYTICS
Contents:
Reaching Value Inflection Points in Neurodegenerative Diseases
BioEquity 2019

Bionure in 4 questions
Q1: Bionure’s focus: Central nervous system and neurodegenerative diseases

Q2: BN201, the lead drug-candidate
Q3: A seasoned team to execute strategy and plans
Q4: Next steps for Bionure & BN201

2

Q1: Bionure’s focus: CNS and neurodegenerative diseases

• Range of conditions ... See more

Recent Presentations

Yalin Firinci
19 August, 2019

Regulatory Science for R&D Promotion

At present, the nation’s policy for Research and Development (R&D) promotion of innovative pharmaceuticals & improvement of environments for the R&D is formulated by Japanese gover

...
18 August, 2019
...
16 August, 2019